Loading…
Employees: 888
Size PROCEPT BioRobotics (PRCT) is a United States Health Care company (Medical Specialties) with a market value of $1.18B, the 2144th largest of 3,117 United States companies the cockpit tracks. Shares closed at $20.62 on 6 Nov 2026.
Performance Over six months the shares fell 18.8%, against -5.5% for the median peer and -1.1% for the United States market (cap-weighted) — 5th lowest of 20 in its peer set.
Growth Revenue grew 22.7% over the last twelve months (peer median +12.5%); the operating margin is -33.9% (peer median 13.9%).
Valuation It trades at 3.0× enterprise value to sales against a peer median of 5.2× (4th cheapest of 19).
Capital Return on invested capital runs 56.6 points below its cost of capital (9.0% WACC).
Short interest Short interest is 13.1% of the free float (15 Oct 2026).
Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $337M | $308M | $224M | $136M | $75.0M |
| Revenue growth | — | +37% | +65% | +82% | — |
| Gross profit | $215M | $196M | $137M | $71.0M | $37.1M |
| EBITDA | -$107M | -$97.5M | -$91.4M | -$105M | -$76.4M |
| Net income | -$110M | -$95.6M | -$91.4M | -$106M | -$87.2M |
| Free cash flow | -$84.9M | -$58.3M | -$104M | -$133M | -$83.0M |
| Capital expenditure | $10.6M | $9.36M | $4.41M | $25.2M | $2.65M |
| Total debt | $77.5M | $78.5M | $80.2M | $79.2M | $77.3M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PRCT | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +15.2% | +1.2% | 5th highest of 21 |
| 6-month return | -18.8% | -5.5% | 5th lowest of 20 |
| Distance from 52-week high | -45.9% | -34.5% | 6th lowest of 21 |
| Revenue growth (TTM) | +22.7% | +12.5% | 4th highest of 19 |
| Operating margin | -33.9% | 13.9% | 3rd lowest of 19 |
| EV / Sales | 3.0× | 5.2× | 4th cheapest of 19 |
| ROIC minus cost of capital | -56.6 pp | -0.2 pp | lowest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| PROCEPT BioRobotics PRCT | United States | $1.18B | -19% | +23% | -34% | 3.0× | n/a | n/a |
| Tandem Diabetes Care TNDM | United States | $1.18B | +9% | +4% | -4% | 1.4× | n/a | n/a |
| Inno Laser Technology 301021.SZ | China | $1.16B | -18% | +17% | 9% | 12.7× | 53.9% | +8.6% |
| Alphatec ATEC | United States | $1.15B | -1% | +15% | -3% | 2.0× | n/a | n/a |
| Mingyue Optical Lens 301101.SZ | China | $1.14B | +6% | +14% | 25% | 6.8× | 10.0% | +8.8% |
| Beijing Strong Biotechnologies 300406.SZ | China | $1.13B | +1% | -4% | 36% | 5.8× | 1.5% | +9.9% |
| Shandong Weigao Orthopaedic Device 688161.SS | China | $1.24B | -25% | -6% | 18% | 5.1× | 12.7% | -3.5% |
| CLASSYS 214150.KS | South Korea | $1.25B | -54% | +25% | 46% | 4.6× | -8.7% | +34.5% |
| Guangzhou Hexin Instrument 688622.SS | China | $1.26B | +58% | -29% | -74% | 99.9× | n/a | n/a |
| Beijing Wandong Medical Technology 600055.SS | China | $1.11B | -27% | -11% | -33% | 3.4× | n/a | n/a |
| IRadimed IRMD | United States | $1.10B | 0% | +11% | 32% | 11.7× | 19.1% | +21.5% |
| STAAR Surgical STAA | United States | $1.26B | -6% | +51% | 18% | 3.3× | n/a | n/a |
| Amoy Diagnostics 300685.SZ | China | $1.10B | -14% | +7% | 34% | 5.2× | 6.5% | +10.3% |
| Eyebright Medical Technology (Beijing) 688050.SS | China | $1.27B | -15% | +21% | 16% | 5.2× | 10.8% | +40.3% |
| Alpha Tau Medical DRTS | United States | $1.27B | +61% | n/a | n/a | n/a | n/a | n/a |
| Freenome FRNM | United States | $1.09B | n/a | n/a | n/a | n/a | n/a | n/a |
| SI-BONE SIBN | United States | $1.09B | +98% | +14% | -8% | 4.5× | n/a | n/a |
| PHC 6523.T | Japan | $1.09B | +36% | +3% | 7% | 1.0× | -2.3% | +3.6% |
| Tinavi Medical Technologies 688277.SS | China | $1.08B | -30% | -2% | -59% | 26.9× | n/a | n/a |
| INKON Life Technology 300143.SZ | China | $1.08B | -14% | +22% | 12% | 3.4× | 12.4% | +12.9% |
| L&C BIO 290650.KS | South Korea | $1.07B | -17% | +53% | 17% | 12.8× | n/a | n/a |